Sign in
8-K

Current Report

Xilio Therapeutics, Inc. Filed Acc 0001193125-26-007063

Results of operations · Executive or director change

  • Item 2.02 Results of operations and financial condition
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing